Colorado Hub for Health Impact, the national economic development campaign positioning Colorado as an epicenter for health innovation, launches its 2025 campaign with new partner investment and a clear focus: attract life sciences companies, talent, and investors to a community that elevates science.
Aurora City Council has approved a massive increase in allowable housing at Fitzsimons Innovation Community, a move intended to transform the bioscience campus into a full-fledged neighborhood. Fitzsimons CEO Kelly Brough called the change “an obligation” to honor the site’s history while shaping a future that attracts talent and builds community.
A change to the Fitzsimons Innovation Community’s master plan in Aurora will allow eight times more residential units to be built on the medical campus.The Aurora City Council on Monday approved an amendment to the general development plan that increases the Fitzsimons Innovation Community residential unit cap from 850 units to 7,266 new units. Changes…
The University of Colorado Cancer Center this year celebrates its 40th anniversary, highlighting significant advances in research and innovations that include new therapies, treatments and insights into cancer prevention. One of the leaders in cell-based immune therapies is CU Cancer Center member Terry Fry, M.D., executive director of the Gates Institute, a translational research institute…
As Fitzsimons Innovation Community celebrates the 25th anniversary, President and CEO Kelly Brough reflects on a remarkable journey of transformation—and an even more ambitious vision for the future. What began as a bioscience incubation campus has evolved into something unprecedented: a thriving ecosystem where researchers, practitioners, educators, and innovators collaborate to bring life-changing healthcare solutions directly to patients.
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder. Rheumatoid arthritis is an autoimmune disease that causes pain and swelling in the joints. It affects about one percent of the adult population. With its HLA gene editing approach, RheumaGen believes it can create a one-time cure for…
A startup is developing a new class of treatments for autoimmune diseases leveraging an approach to editing genes in the HLA family, which play a critical role in the immune system. RheumaGen, which spun out from the University of Colorado Anschutz Medical Campus, launched earlier this year with $15 million in Series A funding co-led…
This year, Fitzsimons Innovation Community is proudly celebrating 25 years of innovation since the grand opening of Bioscience 1 in 2000. For every one of those 25 years—and many before that—Lyle Artz, Site Manager of Fitzsimons Innovation Community, has been here. We were honored to sit down with him and discuss the history, logistics, collaboration, and hard work involved in the early days of the redevelopment of the campus and how all of those elements are still part of the Fitzsimons Innovation Community fabric 25 years later.
A new study from Livability finds a lot to love along the Front Range, naming Aurora, Loveland, and Colorado Springs to a list of the 100 best places to live in the U.S. “Living in Aurora means residents can take full advantage of the city’s excellent amenities and strong economy,” the site said. “Biotech startups,…
Each quarter the Colorado Real Estate Journal publishes its Healthcare and Life Sciences Quarterly to report on the state of commercial real estate in Colorado. The most recent edition includes an article from Fitzsimons and our leasing partners at CBRE to explore the forecast for life sciences real estate markets in our region, and why…